Free Trial
NASDAQ:ADXS

Ayala Pharmaceuticals (ADXS) Stock Price, News & Analysis

Ayala Pharmaceuticals logo
$0.15 +0.03 (+22.36%)
As of 07/11/2025 03:41 PM Eastern

About Ayala Pharmaceuticals Stock (NASDAQ:ADXS)

Key Stats

Today's Range
$0.03
$0.15
50-Day Range
$0.03
$0.15
52-Week Range
$0.00
$0.78
Volume
689 shs
Average Volume
5,516 shs
Market Capitalization
$6.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ADXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ADXS Stock News Headlines

Ayala Pharmaceuticals, Inc. (ADXS) - Yahoo Finance
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
Ayala unit expands cold storage network
Immunome: An Oncology Powerhouse In The Making
See More Headlines

ADXS Stock Analysis - Frequently Asked Questions

Ayala Pharmaceuticals' stock was trading at $0.0270 at the beginning of 2025. Since then, ADXS stock has increased by 445.2% and is now trading at $0.1472.

Ayala Pharmaceuticals, Inc. (NASDAQ:ADXS) announced its earnings results on Thursday, September, 9th. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.04) by $0.02. The company earned $0.25 million during the quarter.

Shares of ADXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ayala Pharmaceuticals investors own include Inovio Pharmaceuticals (INO), Onconova Therapeutics (ONTX), Madrigal Pharmaceuticals (MDGL), Merck & Co., Inc. (MRK), Acasti Pharma (ACST), Bristol Myers Squibb (BMY) and

Company Calendar

Last Earnings
9/09/2021
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ADXS
CIK
1100397
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$3.24 million
Price / Sales
1.94
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($2.06) per share
Price / Book
-0.07

Miscellaneous

Outstanding Shares
42,633,000
Free Float
42,364,000
Market Cap
$6.28 million
Optionable
Not Optionable
Beta
1.17
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:ADXS) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners